(Q28188396)

12 December 2020

Implications of Stroke Risk Criteria on the Anticoagulation Decision in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

1 reference

12 December 2020

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

12 December 2020

Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Antithrombotic therapy in atrial fibrillation

1 reference

12 December 2020

Intensity of anticoagulation to prevent stroke in patients with atrial fibrillation

1 reference

12 December 2020

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

12 December 2020

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

12 December 2020

Prevention of stroke in patients with nonvalvular atrial fibrillation

1 reference

12 December 2020

Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperat

1 reference

12 December 2020

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

12 December 2020

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

1 reference

12 December 2020

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

12 December 2020

[Warfarin therapy for secondary prevention of cardioembolic stroke with nonvalvular atrial fibrillation--a retrospective study]

1 reference

12 December 2020

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

1 reference

12 December 2020

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

12 December 2020

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group

1 reference

12 December 2020

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

12 December 2020

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation

1 reference

12 December 2020

Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study

1 reference

12 December 2020

Atrial fibrillation and stroke. Three new studies, three remaining questions

1 reference

12 December 2020

Intracranial microembolic signals in 500 patients with potential cardiac or carotid embolic source and in normal controls.

1 reference

12 December 2020

Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls

1 reference

12 December 2020

Acute stroke with atrial fibrillation. The Copenhagen Stroke Study.

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study

1 reference

12 December 2020